Biggest News Aggregation in the World
📰 Alpn News

Page 3 - Alpn News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alpn. Real-time updates on events, politics, business and more.

Brokerages Set Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Price Target at $18.14

Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have been given a consensus recommendation of “Buy” by the seven research firms that are covering the company, Marketbeat reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokers that have issued ratings on the […]
Nova Scotia Vanguard Group Inc Institutional Trading Of Alpine Immune Sciences Alpine Immune Sciences Trading Alpine Immune Sciences Great Point Partners

Alpine Immune Sciences (NASDAQ:ALPN) Stock Price Down 6.6%

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price fell 6.6% during trading on Monday . The company traded as low as $11.38 and last traded at $11.38. 132,540 shares changed hands during trading, a decline of 22% from the average session volume of 169,821 shares. The stock had previously closed at $12.19. […]
United States Alpine Immune Sciences Company Profile Alpine Immune Sciences Stock Performance Alpine Immune Sciences Inc Royal Bank Great Point Partners

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Alpine Immune Sciences (NASDAQ:ALPN) Price Target Increased to $22.00 by Analysts at Oppenheimer

Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its price objective boosted by Oppenheimer from $14.00 to $22.00 in a research report released on Monday, MarketBeat reports. Oppenheimer currently has an outperform rating on the biotechnology company’s stock. Several other research firms have also issued reports on ALPN. HC Wainwright restated a buy rating and […]
United States Barclays Plc News Ratings For Alpine Immune Sciences Daily American International Group Inc Analyst Recommendations For Alpine Immune Sciences Alpine Immune Sciences
Source: wkrb13.com

Oppenheimer Boosts Alpine Immune Sciences (NASDAQ:ALPN) Price Target to $22.00

Alpine Immune Sciences (NASDAQ:ALPN – Free Report) had its target price lifted by Oppenheimer from $14.00 to $22.00 in a report issued on Monday, MarketBeat.com reports. They currently have an outperform rating on the biotechnology company’s stock. Other research analysts also recently issued research reports about the company. Wedbush reiterated an outperform rating and issued […]
Analyst Recommendations For Alpine Immune Sciences Vanguard Group Inc Alpine Immune Sciences Company Profile Alpine Immune Sciences Alpine Immune Sciences Stock Down Goldman Sachs Group Inc

Alpine Immune Sciences (NASDAQ:ALPN) Trading Down 4.2%

Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price was down 4.2% during mid-day trading on Tuesday . The company traded as low as $12.27 and last traded at $12.31. Approximately 16,561 shares were traded during trading, a decline of 89% from the average daily volume of 148,825 shares. The stock had previously […]
United States American International Group Inc Royal Bank Alpine Immune Sciences Trading Down News Ratings For Alpine Immune Sciences Daily Barclays Plc

Alpine Immune Sciences' (ALPN) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Alpine Immune Sciences (NASDAQ:ALPN – Free Report) in a research note released on Thursday, Benzinga reports. They currently have a $17.00 price target on the biotechnology company’s stock. Separately, Wedbush boosted their target price on Alpine Immune Sciences from $17.00 to $19.00 and gave the stock […]
News Ratings For Alpine Immune Sciences Daily Alpine Immune Sciences Alpine Immune Sciences Company Profile Vanguard Group Inc Alpine Immune Sciences Inc Blackrock Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science